Clinical Trial Update: Gout Dose Response Study [Phase 2]

View source ↗

Summary

Phase II gout dose-response trial completed; the study sponsored by Ardea Biosciences focused on hyperuricemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Snippet

Sponsor: Ardea Biosciences, Inc. | Conditions: Hyperuricemia | Phase 2 | Status: COMPLETED